JP2002148263A - Method for evaluating and selecting absorptive article - Google Patents
Method for evaluating and selecting absorptive articleInfo
- Publication number
- JP2002148263A JP2002148263A JP2001252209A JP2001252209A JP2002148263A JP 2002148263 A JP2002148263 A JP 2002148263A JP 2001252209 A JP2001252209 A JP 2001252209A JP 2001252209 A JP2001252209 A JP 2001252209A JP 2002148263 A JP2002148263 A JP 2002148263A
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- diaper
- wearer
- immunoglobulin
- urination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 26
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 26
- 230000002745 absorbent Effects 0.000 claims description 34
- 239000002250 absorbent Substances 0.000 claims description 34
- 230000027939 micturition Effects 0.000 claims description 25
- 210000001124 body fluid Anatomy 0.000 claims description 14
- 239000010839 body fluid Substances 0.000 claims description 14
- 210000003296 saliva Anatomy 0.000 claims description 12
- 229940099472 immunoglobulin a Drugs 0.000 claims description 8
- 230000003248 secreting effect Effects 0.000 claims description 5
- 241001591005 Siga Species 0.000 description 32
- 238000010521 absorption reaction Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 230000003746 surface roughness Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- JJHMECBCPWRGMR-UHFFFAOYSA-N 2-[(2-aminophenyl)diazenyl]aniline Chemical compound NC1=CC=CC=C1N=NC1=CC=CC=C1N JJHMECBCPWRGMR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000002011 intestinal secretion Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Landscapes
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、紙オムツ、生理用
ナプキンなどの吸収性物品を、評価、選択する方法に関
する。より詳しくは、体液中の免疫グロブリン濃度を測
定して、該測定値によって着用者自身の生理的および心
理的要求に合致した吸収性物品を評価、選択する方法に
関する。The present invention relates to a method for evaluating and selecting absorbent articles such as disposable diapers and sanitary napkins. More specifically, the present invention relates to a method for measuring an immunoglobulin concentration in a body fluid, and evaluating and selecting an absorbent article that meets the physiological and psychological requirements of the wearer based on the measured value.
【0002】[0002]
【従来の技術】現在、市場では、紙オムツ、生理用ナプ
キン、おりものライナー、母乳パットなどの吸収性物品
は、その大きさ(長さ、厚みなど)、形状、吸収量、価
格等により、分類されて販売されている。そのため、購
入者は、これらの大きさ、形状等の外形、吸収量、価格
等を基準にして、吸収性物品を選択して購入している。
また、売場においても、通常専門の販売員がいないた
め、購入者は、商品棚に配置された物品を、商品パッケ
ージに表示されるサイズ、形状、吸収量などに基づいて
選択して、購入しているのが実状である。2. Description of the Related Art At present, in the market, absorbent articles such as disposable diapers, sanitary napkins, vagina liners, breast milk pads, etc., have different sizes (length, thickness, etc.), shapes, absorption amounts, prices, and the like. Classified and sold. Therefore, the purchaser selects and purchases an absorbent article based on the size, shape, and other external shapes, absorption amount, price, and the like.
In addition, since there is usually no specialized sales person at the sales floor, the purchaser selects and purchases the articles placed on the product shelf based on the size, shape, absorption amount, etc. displayed on the product package. That is the fact.
【0003】例えば、乳幼児用オムツにおいては、体重
によるサイズ(新生児用、S、M、L等)、及び起立歩
行できるか否かによる分類(テープによる組立型、パン
ツ型)によって、大人用紙オムツにおいては、ウエスト
サイズ(S、M、L等)、及び形状によって、購入者が
商品を選択して購入している。しかしながら、乳幼児オ
ムツや大人用紙オムツの場合には、通常購入者と使用者
(着用者)とが異なるために、購入者、すなわち介助者
や介護者などの意向で、大きさや漏れにくさなどから判
断されて商品が選択されているのが通常である。特に、
言語・運動能力の未発達な乳幼児、あるいは痴呆の症状
が出ている高齢者においては、その傾向が強い。[0003] For example, in diapers for babies and infants, depending on the size according to weight (for newborns, S, M, L, etc.) and the classification based on whether or not the user can stand up (assembled with tape, pants type), adult paper diapers are used. Is purchased and selected by the purchaser according to waist size (S, M, L, etc.) and shape. However, in the case of infant diapers and adult paper diapers, since the purchaser and the user (wearer) are usually different, the size, leakage, etc. of the purchaser, It is normal that a product is selected after being determined. In particular,
This tendency is strong in infants with poor language and motor skills or in elderly people who have symptoms of dementia.
【0004】このために、着用者自身の生理的、心理的
要求に合致した商品を選択することになっておらず、結
果として着用者の装着感(肌触り、締め付け感、動き易
さ)に劣る商品を選択してしまう恐れがあり、結果とし
て、人体の外面的に起こるオムツかぶれ(接触皮膚炎)
等の疾患を引き起こしたり、着用者のストレスの原因と
なったりしている。さらには、そのような吸収性物品を
連続的に装用することによる潜在的なストレスによっ
て、着用者の免疫機能が低下する原因となってしまう可
能性がある。[0004] For this reason, products that meet the physiological and psychological requirements of the wearer themselves are not selected, and as a result, the wearer's feeling of wearing (feeling, tightening, and ease of movement) is inferior. Diaper rash (contact dermatitis) on the outside of the human body as a result of the risk of selecting a product
Etc., or cause stress on the wearer. Furthermore, the potential stress of continuous wearing of such an absorbent article can cause the wearer's immune function to decrease.
【0005】また、生理用ナプキンにおいては、吸収量
と長さ(多い日、少ない日)、及び形状(羽根の有無)
などによって、商品を選択して購入している。生理用ナ
プキンの場合には、通常、購入者と使用者(着用者)と
が一致しているために、使用者の体調及び嗜好性(肌触
り、形状、吸収量等)に合う商品を、使用者の使用経験
の中から選択して購入することができるが、使用者自身
が使用経験から認識している生理的、心理的要求が正し
いとは限らず、結果的にストレスの原因となっている場
合がある。さらには、若年層の使用者は、ナプキン使用
経験が少ないために、真の生理的、心理的要求に合致し
た製品を選ぶのが困難であり、その選択基準が嗜好に傾
く傾向がある。In the case of sanitary napkins, the absorption amount, length (large days, small days), and shape (presence or absence of blades)
For example, a product is selected and purchased. In the case of sanitary napkins, since the purchaser and the user (wearer) usually match, use products that match the user's physical condition and taste (feel, shape, absorption amount, etc.). Can be purchased from the user's experience, but the physiological and psychological requirements that the user perceives from the experience are not always correct, and may cause stress. May be. Furthermore, younger users have little experience in using napkins, so it is difficult to select products that meet true physiological and psychological requirements, and the selection criteria tend to be inclined toward taste.
【0006】オムツや生理用ナプキンなどの吸収性物品
の商品開発や製造の現場では、このような市場の現況に
ひきずられ、購入者の嗜好・簡便性を追いかけるあまり
に、商品性能の開発が、着用者自身の真の生理的、心理
的要求から乖離してしまっている可能性がある。しかし
ながら、このような状況を是正するための方法は、従来
開発されておらず、着用者自身の快適性、装着感に合致
した吸収性物品を評価、選択するための適正な指標(メ
ジャー)がないのが実状である。[0006] In the field of product development and manufacture of absorbent articles such as diapers and sanitary napkins, such market conditions have led to the pursuit of purchasers' preferences and simplicity. May deviate from the true physiological and psychological requirements of the individual. However, a method for correcting such a situation has not been developed so far, and an appropriate index (measure) for evaluating and selecting an absorbent article that matches the comfort and wearing feeling of the wearer has been developed. There is no actual situation.
【0007】[0007]
【発明が解決しようとする課題】本発明は、上記のよう
な従来技術の問題点を解決することを課題とする。すな
わち、紙オムツや生理用ナプキンなどの吸収性物品を使
用する着用者自身の生理的、心理的要求に合致した吸収
性物品の評価、選択方法を提供することを課題とする。
より詳細には、オムツや生理用ナプキンなどの吸収性物
品を開発、製造する生産者において、着用者自身の快適
性などの生理的及び心理的要求により近い物品を選択、
評価できる方法、及びオムツや生理用ナプキンなどの吸
収性物品の購入者が着用者自身の生理的、心理的要求に
より合致した物品を選択することができる方法を提供す
ることを課題とする。SUMMARY OF THE INVENTION An object of the present invention is to solve the above-mentioned problems of the prior art. That is, it is an object of the present invention to provide a method of evaluating and selecting an absorbent article that matches the physiological and psychological requirements of a wearer who uses an absorbent article such as a disposable diaper or a sanitary napkin.
More specifically, in producers who develop and manufacture absorbent articles such as diapers and sanitary napkins, select articles that are closer to physiological and psychological requirements such as the wearer's own comfort,
It is an object to provide a method that can be evaluated, and a method that enables a purchaser of an absorbent article such as a diaper or a sanitary napkin to select an article that matches the physiological and psychological requirements of the wearer.
【0008】[0008]
【課題を解決するための手段】本発明者らは、上記の課
題を解決するために、鋭意研究した結果、体液中の免疫
グロブリン濃度を指標(メジャー)とすることによっ
て、吸収性物品を評価、選択できることを見出し、本発
明に至った。本発明者らは、着用者の生理的状況及び心
理的状況を客観的に推測できる指標を種々検討した結
果、免疫グロブリン量に着目し、着用者の体液中の免疫
グロブリン濃度を測定したところ、吸収性物品の快適性
と関係を有することを見出した。言い換えれば、吸収性
物品を装着していて、快適と感じる時と不快と感じる時
とで、着用者の体液中の免疫グロブリン濃度に変化が生
じることを見出し本発明に至ったものである。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have evaluated an absorbent article by using the concentration of immunoglobulin in a body fluid as an index (measure). And found that they can be selected, leading to the present invention. The present inventors have studied various indices that can objectively estimate the physiological state and psychological state of the wearer, and focused on the amount of immunoglobulin, and measured the immunoglobulin concentration in the body fluid of the wearer. It has been found that it has a relationship with the comfort of the absorbent article. In other words, the present inventors have found out that the immunoglobulin concentration in the body fluid of the wearer changes when the user wears the absorbent article and feels comfortable and when the user feels uncomfortable.
【0009】すなわち本発明は、(1)体液中の免疫グ
ロブリン濃度を指標として、吸収性物品の良否を評価す
る方法、(2)着用者の体液中の免疫グロブリン濃度を
指標として、着用者に合致した吸収性物品を選択する方
法、(3)吸収性物品を着用した着用者の体液中の免疫
グロブリン濃度を、排尿前と排尿後とに測定し、排尿前
後の該免疫グロブリン濃度の変化率を求め、該変化率を
指標として用いる上記(1)または(2)の方法、
(4)体液が唾液である上記(1)〜(3)のいずれか
の方法、(5)免疫グロブリンが、分泌型免疫グロブリ
ンAであることを特徴とする(1)〜(4)のいずれか
の方法、に関するものである。That is, the present invention provides (1) a method for evaluating the quality of an absorbent article using an immunoglobulin concentration in a body fluid as an index, and (2) a method for evaluating a wearer using the immunoglobulin concentration in a body fluid of the wearer as an index. (3) measuring the immunoglobulin concentration in the body fluid of the wearer wearing the absorbent article before and after urination, and changing the immunoglobulin concentration before and after urination And the method of the above (1) or (2), wherein the change rate is used as an index,
(4) The method according to any one of (1) to (3) above, wherein the body fluid is saliva, and (5) the immunoglobulin is secretory immunoglobulin A, wherein (1) to (4). Method.
【0010】本発明では、体液中の免疫グロブリン濃
度、あるいはその変化率を指標として吸収性物品を評価
することで、着用者自身の快適性などの生理的、心理的
要求に合致した吸収性物品を客観的且つ簡便に選択、評
価できるという効果を奏することができる。According to the present invention, an absorbent article which meets physiological and psychological requirements such as comfort of the wearer is evaluated by evaluating the absorbent article using the immunoglobulin concentration in the body fluid or the rate of change thereof as an index. Can be objectively and easily selected and evaluated.
【0011】[0011]
【発明の実施の形態】以下に、本発明を詳細に説明する
が、本発明は、これに限定されるものではない。本発明
における吸収性物品には、紙オムツ、生理用ナプキン、
生理用タンポン、陰唇間吸収性パッド、おりものライナ
ー、母乳パットが挙げられるが、その他、本発明は、失
禁用ショーツ等にも適用できる。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail, but the present invention is not limited thereto. The absorbent article according to the present invention includes a paper diaper, a sanitary napkin,
Mention may be made of sanitary tampons, interlabial absorbent pads, vaginal liners and breast milk pads, but the invention is also applicable to incontinence shorts and the like.
【0012】免疫とは、細菌などの生体外から生体内の
環境に侵入してくる異物によって、生体の内部環境が攪
乱されるのを防ぎ、生体の恒常性を維持するための機構
であり、免疫に関与するタンパク質の代表的なものに
は、リンパ球、マクロファージ、好中球、免疫グロブリ
ンがある。免疫グロブリンは、IgD、IgG、IgE、IgA、Ig
Mなどに分類されるが、IgA(免疫グロブリンA)は、外
分泌液中の主要な免疫グロブリンで、粘膜表面の感染防
止に役立っている。IgAは、唾液、鼻汁、腸や気管の分
泌液中に多くみられるが血清中にも存在する。[0012] Immunity is a mechanism for preventing the internal environment of a living body from being disturbed by foreign substances such as bacteria that enter the living body environment from outside the living body, and maintaining the homeostasis of the living body. Representative proteins involved in immunity include lymphocytes, macrophages, neutrophils, and immunoglobulins. Immunoglobulins include IgD, IgG, IgE, IgA, Ig
Although classified into M and the like, IgA (immunoglobulin A) is a major immunoglobulin in the exocrine fluid and helps prevent infection on mucosal surfaces. IgA is commonly found in saliva, nasal secretions, intestinal and tracheal secretions, but is also present in serum.
【0013】IgD、IgG、IgE、IgM等を測定に応用しよう
とすると血液を収集する必要があるが、分泌型免疫グロ
ブリン(sIgA)を測定する場合には、唾液を収集して
分析すればよいので、被験者に苦痛を与えることがな
い。血液を採取するためには、注射針等により皮膚を傷
つける必要があり、その苦痛自体がストレスとなるのみ
ならず、傷口より感染症を引き起こす可能性があるので
避けることが好ましい。本発明では、このような観点か
ら、唾液中の分泌型免疫グロブリン(sIgA)を測定す
るのが好ましい。When applying IgD, IgG, IgE, IgM, etc. to the measurement, blood must be collected, but when secretory immunoglobulin (sIgA) is measured, saliva may be collected and analyzed. Therefore, no pain is given to the subject. In order to collect blood, it is necessary to injure the skin with an injection needle or the like, and the pain itself is not only a stress but also may cause an infection from the wound, so it is preferable to avoid it. In the present invention, from such a viewpoint, it is preferable to measure secretory immunoglobulin (sIgA) in saliva.
【0014】唾液中の分泌型免疫グロブリンA(sIg
A)の測定は、sIgAが測定できる手段であればどのよう
な手段であっても良い(ラジオイムノアッセイやサンド
イッチ抗体法)が、以下に、sIgA濃度の測定法の一例
を示す(日本生理人類学会計測研究部会編「人間科学計
測ハンドブック」技報堂出版430〜432頁参照)。Secretory immunoglobulin A (sIg) in saliva
The measurement of A) may be performed by any means capable of measuring sIgA (radioimmunoassay or sandwich antibody method). The following is an example of a method for measuring the sIgA concentration (Japanese Society of Physiological Anthropology) (See Handbook of Human Science Measurements, edited by the Measurement Research Subcommittee, published by Gihodo pp. 430-432).
【0015】[唾液の収集方法]約3cmに切断した綿花
を5〜6個準備し、被験者のほっぺたの裏などに詰め込
み、5分間放置する。この唾液を吸収した綿花を遠心分
離機に投入し、3000rpmで5分間遠心分離を行い、唾液
のみを分離回収する。[Method of collecting saliva] Five to six cotton pieces cut to about 3 cm are prepared, packed in the back of a cheek of a subject, and left for 5 minutes. The cotton that has absorbed the saliva is put into a centrifuge, and centrifuged at 3000 rpm for 5 minutes to separate and collect only the saliva.
【0016】[sIgAの測定手順]測定は、「EIA s
−IgAテストキット((株)MBL社製)」を用いて
次のように行った。 1)検体の添加 (i)回収,遠心分離した唾液を20,50,100倍
に希釈する。 (ii)試験管に反応用緩衝液を0.4ml入れ、希釈し
た検体を10μl加え良く混和する。 2)一次反応 (i)抗ヒトセクレタリーコンポーネント結合ポリスチ
レンボールを試験管に加える。 (ii) 37℃で、1時間静置 加温する。 3)洗浄 (i)反応終了後、反応液を吸引除去する。 (ii)リン酸緩衝液を1ml加え、良く振とうした後、
吸引除去する。 (iii)(i)及び(ii)の操作を2回繰り返す。 4)二次反応 (i)上記操作を終えた試験管に 酵素(ペルオキシター
ゼ)標識抗ヒトIgAを0.3ml加える。 (ii)20℃で、一時間静置する。 5)洗浄 上記3)と同じ洗浄を3回繰り返し行う。 6)酵素反応 (i)新しい試験管に酵素基質(δ−フェニレンジアミ
ン)液を0.5ml加え、その中に 5)の洗浄が終わっ
たポリスチレンボールを入れる。 (ii)20℃で、30分間静置する。 7)反応停止 6)の酵素反応終了後、試験管に1規定硫酸を2ml加
え、反応を停止させる。 8)吸光度測定 反応によって生じた2,2’-ジアミノアゾベンゾール
の生成量を、分光光度計を用いて、波長492nmの吸
光度を測定し、標準曲線にあてはめて、s-IgA濃度を
求める。[Procedure for measuring sIgA] The measurement was performed using “EIA s
-IgA test kit (manufactured by MBL Co., Ltd.) "as follows. 1) Addition of sample (i) The saliva collected and centrifuged is diluted 20, 50 and 100 times. (Ii) 0.4 ml of the reaction buffer is placed in a test tube, and 10 μl of the diluted sample is added and mixed well. 2) Primary reaction (i) Add anti-human secretary component-bound polystyrene balls to test tubes. (ii) Incubate at 37 ° C for 1 hour. 3) Washing (i) After completion of the reaction, the reaction solution is removed by suction. (Ii) After adding 1 ml of phosphate buffer and shaking well,
Remove by suction. (Iii) The operations of (i) and (ii) are repeated twice. 4) Secondary reaction (i) Add 0.3 ml of enzyme (peroxidase) -labeled anti-human IgA to the test tube after the above operation. (Ii) Leave at 20 ° C. for one hour. 5) Washing The same washing as in the above 3) is repeated three times. 6) Enzyme reaction (i) To a new test tube, add 0.5 ml of the enzyme substrate (δ-phenylenediamine) solution, and put the polystyrene ball in which the washing of 5) is completed. (Ii) Let stand at 20 ° C. for 30 minutes. 7) Termination of reaction After completion of the enzyme reaction in 6), add 2 ml of 1N sulfuric acid to the test tube to stop the reaction. 8) Measurement of absorbance The amount of 2,2'-diaminoazobenzol produced by the reaction is measured for absorbance at a wavelength of 492 nm using a spectrophotometer, and is applied to a standard curve to determine the s-IgA concentration.
【0017】このようにして測定したsIgA濃度と吸収
性物品の装着感との関係をオムツを用いて試験した。試
験のために下記の2種類のパンツ型オムツを準備した。The relationship between the sIgA concentration thus measured and the feeling of wearing the absorbent article was tested using a diaper. The following two types of pants-type diapers were prepared for the test.
【表1】 注)吸収速度:200mlの生理食塩水をオムツ表面に投
入し、生理食塩水の全量がトップシートから吸収される
までの時間。 リウェット量:200mlの生理食塩水を投入して、5分
後にトップシート表面に35g/cm2荷重下でろ紙を置
き、ろ紙に吸収された生理食塩水の量。 吸収量:オムツ全体を30分間生理食塩水に浸漬し、引
き上げて、35g/cm2荷重下で、20分間水を切った重
量から、吸収前の重量を引いたもの。(g/pは、オム
ツ一つ当たりの吸収重量を表わす)。 保水量:吸収量の測定操作後、150Gで90秒間遠心
脱水した重量から、吸収前重量を引いたもの。 ここで、オムツIは、吸収速度、リウェット量、吸水
量、保水量ともに高い機能性の良好なオムツを代表する
サンプルであり、オムツIIは、吸収速度、リウェット
量、吸水量、保水量ともに低い機能性の劣るオムツを代
表するサンプルである。[Table 1] Note) Absorption rate: The time until 200 ml of physiological saline is injected into the diaper surface and the entire amount of physiological saline is absorbed from the top sheet. Re-wet amount: 200 ml of physiological saline was charged, and after 5 minutes, a filter paper was placed under a load of 35 g / cm 2 on the top sheet surface, and the amount of physiological saline absorbed by the filter paper. Absorbed amount: The whole diaper was immersed in physiological saline for 30 minutes, pulled up, and the weight before water absorption was subtracted from the weight of water drained under a load of 35 g / cm 2 for 20 minutes. (G / p represents the absorbed weight per diaper). Water retention: What was obtained by subtracting the weight before absorption from the weight after centrifugal dehydration at 150 G for 90 seconds after the operation of measuring the absorption. Here, diaper I is a sample that represents a diaper having a high functionality and a high absorption rate, rewet amount, water absorption amount, and water retention amount, and diaper II is a low absorption rate, rewet amount, water absorption amount, and water retention amount. This is a sample that represents a diaper with poor functionality.
【0018】[装着試験]7人の成人パネラーA〜Gに
よって、装着試験を実施した。室温28℃、湿度60R
H%の部屋において、パネラーに前記のオムツIとオム
ツIIとを装着させ、25分後に37℃模擬尿をシリコン
チューブを用いてオムツ股間部に投入し、そのまま25
分間装着し続けた。各パネラーについて、模擬尿を排尿
する前と、排尿した直後とのsIgA濃度(ng/ml)を前記
の測定方法により測定した。[Wearing test] A wearing test was carried out by seven adult panelists A to G. Room temperature 28 ° C, Humidity 60R
In the room of H%, the diaper I and the diaper II were attached to the panelists, and after 25 minutes, 37 ° C. simulated urine was poured into the diaper crotch portion using a silicone tube, and then the diaper was caught at 25%.
Continued wearing for minutes. For each panel, the sIgA concentration (ng / ml) before and immediately after urinating the simulated urine was measured by the measurement method described above.
【0019】結果を表2に示した。The results are shown in Table 2.
【表2】 [Table 2]
【0020】表2の結果によると、機能性の良いオムツ
Iでは、機能性の劣るオムツIIより排尿後のsIgA濃度が
高く、また、排尿後のsIgA濃度が排尿前に比べて顕著
に増加するのに対して、機能性の劣るオムツIIでは、そ
の増加率が少ない。表2には、排尿前後のsIgA濃度の
変化率も示した。排尿前に対する排尿後のsIgA濃度の
変化率をみると、機能性の良いオムツIは、7人のパネ
ラーの平均で61.2%であるのに対して、機能性の劣
るオムツIIでは、25.8%である。According to the results shown in Table 2, the diaper has good functionality.
In the case of diaper II, sIgA concentration after urination was higher than that of inferior diaper II, and the sIgA concentration after urination increased remarkably compared to that before urination. Low rate. Table 2 also shows the rate of change of the sIgA concentration before and after urination. Looking at the rate of change in sIgA concentration before and after urination, the diaper I with good functionality was 61.2% on average among seven panelists, whereas the diaper II with poor functionality was 25% in diaper II with poor functionality. 0.8%.
【0021】この結果から、機能性の良好なオムツにお
いては、排尿後のsIgA濃度が高いこと、また排尿前後
のsIgA濃度の変化率が有意に高いことが分かった。逆
に言うと、排尿後のsIgA濃度および/又はsIgA濃度の
排尿前後の変化率を測定することにより、オムツの良否
を評価、判断できることが判った。この結果は、オムツ
の開発現場あるいは生産現場において、sIgA濃度及び
その変化率がオムツの良否の評価指標となることを示す
だけでなく、乳幼児あるいは高齢者などの装着感を言語
で表現できない着用者自身が、快適であり装着感が良い
と感じるオムツを選択するための指標としても応用でき
ることを示す。From these results, it was found that the diaper having good functionality had a high sIgA concentration after urination and a significantly high change rate of the sIgA concentration before and after urination. Conversely, it was found that the quality of the diaper can be evaluated and judged by measuring the sIgA concentration after urination and / or the change rate of the sIgA concentration before and after urination. This result not only indicates that the sIgA concentration and its rate of change at the diaper development site or production site can be used as an evaluation index of the quality of the diaper, but also for wearers who cannot express the feeling of wearing such as infants or the elderly in language. It shows that it can be applied as an index for selecting a diaper that feels comfortable and has a good fit.
【0022】この結果を応用すれば、試着者のsIgA濃
度及び排尿前後のsIgA濃度の変化率が高いオムツを開
発、生産することで、使用者(着用者)に適切な製品の
提供が可能になるという優れた効果を奏することができ
る。また、オムツIを装着することにより、オムツIIを
装着する場合より、着用者のsIgA濃度を増加させるこ
とができるのであるから、この評価で選択されたオムツ
の着用を続けることにより、使用者の免疫の増強をはか
れることが予測される。By applying this result, it is possible to develop and produce a diaper having a high rate of change in the sIgA concentration of a try-on person and the sIgA concentration before and after urination, thereby providing a suitable product to a user (wearer). It is possible to achieve an excellent effect of becoming. Also, by wearing diaper I, it is possible to increase the sIgA concentration of the wearer as compared with wearing diaper II, so by continuing to wear the diaper selected in this evaluation, It is expected that immunity will be enhanced.
【0023】以上、オムツの吸収性能の差と、免疫グロ
ブリン濃度との関係を示して本発明を説明したが、吸収
性物品の肌触り、締め付け感、動き易さなど、その他の
物性に関しても、同様の手法により免疫の状態を測定す
ることにより、着用者に適切な機能を有する吸収性物品
の選択が可能である。また、オムツを例にとって、免疫
グロブリン濃度との関係を試験したが、オムツ以外の吸
収性物品においても同様の結果が予測される。Although the present invention has been described above by showing the relationship between the difference in the absorption performance of diapers and the immunoglobulin concentration, the same applies to other physical properties of the absorbent article, such as feel, tightening, and ease of movement. By measuring the state of immunity according to the method described above, it is possible to select an absorbent article having a function appropriate for the wearer. Further, the relationship with the immunoglobulin concentration was tested using diapers as an example, but similar results are expected for absorbent articles other than diapers.
【0024】[0024]
【実施例】以下に、本発明の実施例を示すが、本発明は
これに限定されるものではない。EXAMPLES Examples of the present invention will be described below, but the present invention is not limited to these examples.
【実施例1】実施例1として、オムツの実施例を示す。
吸収性能の異なる3種のオムツI〜III(表3参照)を
7人の成人パネラーに装着させた。室温28℃、湿度6
0RH%の部屋において、パネラーに上記オムツを装着
させ、25分後に37℃模擬尿をシリコンチューブを用
いてオムツ股間部に投入し、そのまま25分間装着し続
けた。Embodiment 1 As Embodiment 1, an embodiment of a diaper will be described.
Three diapers I to III having different absorption performances (see Table 3) were attached to seven adult panelists. Room temperature 28 ° C, Humidity 6
In a room of 0 RH%, the diapers were mounted on panelists, and after 25 minutes, simulated urine at 37 ° C. was injected into the diaper crotch using a silicone tube, and was continuously worn for 25 minutes.
【0025】[sIgA濃度]各パネラーについて、模擬
尿を排尿する前と、排尿した直後とのsIgA濃度(ng/m
l)を前記の測定方法により測定した。7人のパネラー
で得られたsIgA濃度平均値を排尿前後のsIgA濃度変化
率と共に表4に示す。[SIgA Concentration] For each panelist, the sIgA concentration (ng / m 2) was measured before urination of the simulated urine and immediately after urination.
l) was measured by the measurement method described above. Table 4 shows the average sIgA concentration obtained from the seven panelists together with the rate of change in sIgA concentration before and after urination.
【0026】[快適度] 排尿後の着用者の快適度を次の3段階で評価した。 3:排尿前の装着感と比較して、殆ど変わらない。 2:排尿前の装着感と比較して、やや不快。 1:排尿前の装着感と比較して、不快。 7人のパネラーの平均値を表4に示す。[Comfort] The comfort of the wearer after urination was evaluated on the following three levels. 3: Almost no change compared to the feeling of wearing before urination. 2: Slightly uncomfortable compared to the feeling of wearing before urination. 1: Discomfort compared to the feeling of wearing before urination. Table 4 shows the average values of the seven panelists.
【0027】[皮膚状態の観察]各オムツを介護が必要
な老人の被験者に装着させ、1日平均7枚交換し、5日
間使用した後、肌の状態を目視で観察した。結果を表4
に示す。[Observation of skin condition] Each diaper was worn by an elderly subject in need of nursing care, the average of seven diapers was changed daily, and after 5 days of use, the condition of the skin was visually observed. Table 4 shows the results
Shown in
【0028】[0028]
【表3】 [Table 3]
【0029】[0029]
【表4】 [Table 4]
【0030】表3および表4の結果から、排尿後のsIg
A濃度と排尿前後のsIgA濃度の変化率とは着用者の快適
度と比例することが確認された。また、排尿後のsIgA
濃度とsIgA濃度の変化率の高いオムツは着用者の皮膚
に対しても優れていることが確認された。From the results in Tables 3 and 4, sIg after urination was obtained.
It was confirmed that the A concentration and the rate of change of the sIgA concentration before and after urination were proportional to the comfort of the wearer. In addition, sIgA after urination
It was confirmed that the diaper having a high rate of change in the concentration and the sIgA concentration was also excellent on the skin of the wearer.
【0031】[0031]
【実施例2】実施例2には、女性用吸収性物品の実施例
を示す。 [サンプル]性能の異なる2種の生理用ナプキンIおよ
びII(表5参照)を準備した。Example 2 Example 2 shows an example of an absorbent article for women. [Sample] Two types of sanitary napkins I and II (see Table 5) having different performances were prepared.
【表5】 注)表面のすべりにくさ:自動表面試験機(カトーテッ
ク社KES FB−4S)を用いて測定したMIU値(平
均摩擦係数)。値が大きくなるほど表面がすべりにくく
なることを示す。 表面のざらつき:自動表面試験機(カトーテック社 K
ES FB−4S)を用いて測定したMMD値(摩擦係数
の変動)。値が大きくなるほど表面のざらつきが大きく
なることを示す。 表面粗さ:自動表面試験機(カトーテック社 KES
FB−4S)を用いて測定したSMD値(表面厚さの変
動)。値が大きくなるほど表面が粗くなることを示す。 なお、MIU値、MMD値、SMD値は、布、紙、不織布などの
フィルム状の試料の表面特性を表すためによく用いられ
ている指標である(川端季雄著「繊維工学」Vol.33,No.
2(1980)pp136〜142参照)。[Table 5] Note) Hardness of surface slip: MIU value (average friction coefficient) measured using an automatic surface tester (KES FB-4S, manufactured by Kato Tech). The larger the value, the harder the surface slips. Surface roughness: automatic surface tester (Kato Tech K
MFD value (fluctuation in friction coefficient) measured using ES FB-4S). The higher the value, the greater the surface roughness. Surface roughness: Automatic surface tester (Kato Tech KES)
SMD value (fluctuation in surface thickness) measured using FB-4S). The higher the value, the rougher the surface. The MIU value, MMD value, and SMD value are indices that are often used to represent the surface characteristics of a film-like sample such as cloth, paper, and nonwoven fabric (Kikawa Kawabata, Textile Engineering, Vol. 33, No.
2 (1980) pp136-142).
【0032】[装着試験]室温26℃、湿度60RH%
の部屋において、パネラー15人にナプキンIとIIを装
着させた。パネラーはすべて、月経周期が規則的である
20歳代の女性で、月経開始後7〜10日目である。パ
ネラーは、入室後、座位にて20分間安静にした後、ナ
プキンIもしくはIIを装着し、その後安静状態のまま装
着を続けた。[Wearing test] Room temperature 26 ° C, humidity 60RH%
In the room, 15 panelists were fitted with napkins I and II. All panelists are women in their twenties with regular menstrual cycles, 7 to 10 days after the onset of menstruation. After entering the room, the panelist rested in a sitting position for 20 minutes, then put on napkin I or II, and continued wearing it in a resting state.
【0033】[sIgA濃度][SIgA concentration]
【0015】〜[0015]
【0016】に記載された方法で、パネラーから唾液を
採取してsIgA濃度を測定した。sIgA濃度の測定は、ナ
プキンIまたはIIを装着直後(入室30分後)と入室9
0分後に行った。15人のパネラーの平均値を、その増
加率の平均値とともに表6に示した。[0016] Saliva was collected from panelists and the sIgA concentration was measured by the method described in (1). The sIgA concentration was measured immediately after the napkin I or II was attached (30 minutes after entering the room) and after 9 minutes.
Performed after 0 minutes. The average of the 15 panelists is shown in Table 6 together with the average of the rate of increase.
【0034】[官能評価方法]入室後90分の時点で、
ナプキンIまたはIIについて、下記の5段階でゴワゴワ
感を官能評価した。 1:非常に柔らかく感じる。 2:柔らかく感じる。 3:どちらともいえない。 4:ゴワゴワする。 5:非常にゴワゴワする。 15人のパネラーの平均値を表6に示した。[Sensory Evaluation Method] At 90 minutes after entering the room,
The napkin I or II was subjected to a sensory evaluation of the rough feeling on the following five levels. 1: I feel very soft. 2: Feels soft. 3: Neither can be said. 4: Gogowawa. 5: Very rough. Table 6 shows the average values of 15 panelists.
【0035】[0035]
【表6】 [Table 6]
【0036】表6のナプキンIとIIの結果から、ゴワゴ
ワ感のないナプキンIの方が、唾液中のsIgA濃度の増加
率が大きいことが確認された。また、ナプキンIの方が
sIgA濃度の増加率が大きいことから、ナプキンIの方
が免疫性を高める効果があるといえる。以上のことか
ら、女性用の吸収性物品においても、表面の物理的特性
の違いによる装着感の違いを、人体内面の免疫状態から
評価・選択することが可能であることが分かった。この
ことは、女性用吸収性物品の開発あるいは生産現場にお
いて、体液中の免疫グロブリン濃度及びその変化率が女
性用吸収性物品の良否の評価基準となることを示すだけ
でなく、体液中の免疫グロブリン濃度から着用者自身の
装着感を客観的に評価することができることも示す。From the results of napkins I and II in Table 6, it was confirmed that napkin I having no rough feeling had a larger increase rate of sIgA concentration in saliva. Further, since napkin I has a larger increase rate of sIgA concentration, it can be said that napkin I has an effect of enhancing immunity. From the above, it was found that even in the absorbent article for women, it is possible to evaluate and select the difference in the feeling of wearing due to the difference in the physical properties of the surface from the immune state of the human body. This not only indicates that the concentration of immunoglobulins in body fluids and the rate of change in the development or production of women's absorbent articles are evaluation criteria for the quality of women's absorbent articles. It also shows that the wearing feeling of the wearer can be objectively evaluated from the globulin concentration.
【0037】[0037]
【発明の効果】本発明により、免疫グロブリンを指標と
すれば、適切な機能を有する吸収性物品の評価が客観的
にできるので、適切な機能を有する吸収性物品を開発し
て提供するのに役立てることができる。また、着用者の
sIgA濃度及びその排尿前後の変化率を測定することに
より、着用者の快適性に合致した吸収性物品を選択購入
することが可能になる。According to the present invention, if immunoglobulin is used as an index, an absorbent article having an appropriate function can be objectively evaluated. Therefore, it is possible to develop and provide an absorbent article having an appropriate function. Can help. Also, by measuring the sIgA concentration of the wearer and the rate of change thereof before and after urination, it becomes possible to select and purchase an absorbent article that matches the comfort of the wearer.
Claims (5)
て、吸収性物品の良否を評価する方法。1. A method for evaluating the quality of an absorbent article using an immunoglobulin concentration in a body fluid as an index.
指標として、着用者に合致した吸収性物品を選択する方
法。2. A method for selecting an absorbent article suitable for a wearer using an immunoglobulin concentration in a body fluid of the wearer as an index.
免疫グロブリン濃度を、排尿前と排尿後とに測定し、排
尿前後の該免疫グロブリン濃度の変化率を求め、該変化
率を指標として用いることを特徴とする請求項1または
2に記載の方法。3. The immunoglobulin concentration in the body fluid of the wearer wearing the absorbent article is measured before and after urination, the rate of change of the immunoglobulin concentration before and after urination is determined, and the change rate is used as an index. The method according to claim 1, wherein the method is used as:
ずれかに記載の方法。4. The method according to claim 1, wherein the body fluid is saliva.
ンAであることを特徴とする請求項1ないし4のいずれ
かに記載の方法。5. The method according to claim 1, wherein the immunoglobulin is secretory immunoglobulin A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001252209A JP2002148263A (en) | 2000-09-01 | 2001-08-23 | Method for evaluating and selecting absorptive article |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-265695 | 2000-09-01 | ||
| JP2000265695 | 2000-09-01 | ||
| JP2001252209A JP2002148263A (en) | 2000-09-01 | 2001-08-23 | Method for evaluating and selecting absorptive article |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002148263A true JP2002148263A (en) | 2002-05-22 |
Family
ID=26599090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001252209A Pending JP2002148263A (en) | 2000-09-01 | 2001-08-23 | Method for evaluating and selecting absorptive article |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002148263A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004344532A (en) * | 2003-05-23 | 2004-12-09 | Daio Paper Corp | Body fluid absorbent product, method for evaluating the same, and method for producing the same |
| WO2011155463A1 (en) * | 2010-06-11 | 2011-12-15 | ユニ・チャーム株式会社 | Method for quantitative evaluation of comfortableness of disposable diaper |
| US20210215660A1 (en) * | 2018-05-29 | 2021-07-15 | Kao Corporation | Method for evaluating comfort evoking performance of sheet and comfort evoking sheet |
-
2001
- 2001-08-23 JP JP2001252209A patent/JP2002148263A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004344532A (en) * | 2003-05-23 | 2004-12-09 | Daio Paper Corp | Body fluid absorbent product, method for evaluating the same, and method for producing the same |
| WO2011155463A1 (en) * | 2010-06-11 | 2011-12-15 | ユニ・チャーム株式会社 | Method for quantitative evaluation of comfortableness of disposable diaper |
| JP2011255122A (en) * | 2010-06-11 | 2011-12-22 | Unicharm Corp | Method for quantitative evaluation of comfortableness of disposable diaper |
| US20210215660A1 (en) * | 2018-05-29 | 2021-07-15 | Kao Corporation | Method for evaluating comfort evoking performance of sheet and comfort evoking sheet |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Davis et al. | Comparison of disposable diapers with fluff absorbent and fluff plus absorbent polymers: effects on skin hydration, skin pH, and diaper dermatitis | |
| Varendi et al. | Soothing effect of amniotic fluid smell in newborn infants | |
| Fleming et al. | Postpartum factors related to mother's attraction to newborn infant odors | |
| Osterholm et al. | Tri-state toxic-shock syndrome study. I. Epidemiologic findings | |
| Storr | Prevention of nipple tenderness and breast engorgement in the postpartal period | |
| JP6694096B2 (en) | Evaluation method of pleasant emotion evoking performance of seat and pleasant emotion evoking sheet | |
| Campling | Better lives | |
| Sugar et al. | Common gynecologic problems in prepubertal girls | |
| Pries et al. | The EEC syndrome | |
| US7066006B2 (en) | Method of collecting data relating to attributes of personal care articles and compositions | |
| Vázquez-Nava et al. | Allergic rhinitis, feeding and oral habits, toothbrushing and socioeconomic status: effects on development of dental caries in primary dentition | |
| JP2002148263A (en) | Method for evaluating and selecting absorptive article | |
| US20020052010A1 (en) | Method of evaluation and selection of absorbent article | |
| DeMarinis et al. | Absorbent products for incontinence | |
| TWI334345B (en) | ||
| Boiko | Diapers and diaper rashes | |
| Smith | A Treatise on the Diseases of Infancy and Childhood | |
| Beber | Freedom for the incontinent | |
| JP3837034B2 (en) | Absorbent article evaluation and selection method | |
| JP3707773B2 (en) | Absorbent article evaluation and selection method | |
| JP2002159460A (en) | Method of evaluating and choosing absorbent item | |
| US20020055686A1 (en) | Method of evaluation and selection of absorbent article | |
| WO2019230647A1 (en) | Method for evaluating comfort evoking performance of sheet and comfort evoking sheet | |
| Morse et al. | Leaking: A problem of lactation | |
| JP2002172098A (en) | Method for evaluating and selecting absorptive article |